Baxion
Screening
Tags
Alerts
Theme
Tenax Therapeutics, Inc.
TENX
·
NASDAQ
·
$11.98
Share Price as of 11/2
·
$206M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
07/31/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/10/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/13/25
Disclosures
Filter
8-K
Current report
10/08/26
8-K
Current report
09/09/26
8-K
Current report
08/10/26
8-K
Current report
07/31/26
8-K
Current report
07/02/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
05/12/26
S-3
Shelf registration
03/24/26
424B3
Prospectus
04/23/25
S-3
Shelf registration
04/15/25
S-8
Registration of securities for employees
11/26/24
Proxies
Filter
DEF 14A
Definitive proxy
04/22/26
DEFA14A
Additional proxy materials
04/22/26
DEF 14A
Definitive proxy
04/25/25
DEFA14A
Additional proxy materials
04/25/25
PRE 14A
Preliminary proxy
04/09/25
Ownership
Filter
Form 4
Insider transaction
10/21/26
SC 13G/A
Beneficial ownership (amended)
10/15/26
SC 13G/A
Beneficial ownership (amended)
10/13/26
SC 13G/A
Beneficial ownership (amended)
10/09/26
Form 4
Insider transaction
09/17/26
Other
Filter
ARS
Annual report to shareholders
04/22/26
EFFECT
Request for effectiveness
04/01/26
CORRESP
Correspondence with the SEC
03/31/26
UPLOAD
Letter from the SEC
03/27/26
ARS
Annual report to shareholders
04/25/25
Latest Filings
Filter
8-K
Current report
10/08/26
8-K
Current report
09/09/26
8-K
Current report
08/10/26
10-Q
Q2 ended 06/30/26
07/31/26
8-K
Current report
07/31/26
Ownership
Filter
Form 4
Insider transaction
10/21/26
SC 13G/A
Beneficial ownership (amended)
10/15/26
SC 13G/A
Beneficial ownership (amended)
10/13/26
SC 13G/A
Beneficial ownership (amended)
10/09/26
Form 4
Insider transaction
09/17/26